{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:56:39Z","timestamp":1794844599358,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["30710"],"award-info":[{"award-number":["30710"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23029"],"award-info":[{"award-number":["23029"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21420"],"award-info":[{"award-number":["21420"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["27012"],"award-info":[{"award-number":["27012"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["20-0188"],"award-info":[{"award-number":["20-0188"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The highly fibrotic microenvironment of pancreatic ductal adenocarcinoma (PDAC) poses significant challenges for effective treatment, particularly in drug delivery and tumor progression. Our study investigates the role of collagen dynamics in PDAC, revealing that TGF-\u03b21 negatively regulates the expression of L1 cell adhesion molecule (L1CAM), leading to a more invasive tumor phenotype. We identify a subset of PDAC cells with low L1CAM expression (L1\n                    <jats:sub>low<\/jats:sub>\n                    ) that actively influences collagen deposition and remodeling, as evidenced by the upregulation of collagen 17A1 (COL17A1) and matrix metalloproteinase 2 (MMP2), both associated with poor prognosis. In vivo studies demonstrate that L1\n                    <jats:sub>low<\/jats:sub>\n                    cells correlate with increased collagen deposition, reduced sensitivity to gemcitabine, and heightened liver metastasis. The secretion of COL17A1 and MMP2 by these cells enhances their migratory capabilities and contributes to the formation of a fibrotic stroma that facilitates tumor progression. This interaction underscores the critical role of collagen in shaping the tumor microenvironment and promoting aggressive tumor behavior. Notably, treatment with Tranilast significantly reduced collagen deposition and MMP2 levels while promoting L1CAM expression, suggesting a therapeutic avenue for counteracting the aggressive characteristics of L1\n                    <jats:sub>low<\/jats:sub>\n                    cells. By modulating collagen dynamics and enhancing drug delivery, Tranilast may improve treatment outcomes for patients with low L1CAM-expressing tumors. Understanding the mechanisms by which L1\n                    <jats:sub>low<\/jats:sub>\n                    cells contribute to collagen secretion and tumor aggressiveness is essential for developing effective interventions in pancreatic cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07859-8","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:46:37Z","timestamp":1754462797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["TGF-\u03b21-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-2778","authenticated-orcid":false,"given":"Donatella Delle","family":"Cave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-3660","authenticated-orcid":false,"given":"Marco","family":"Fantuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Ciotola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mangini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buonaiuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Andolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cucciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-6879","authenticated-orcid":false,"given":"Alessandro","family":"Carrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-7651","authenticated-orcid":false,"suffix":"Jr","given":"Bruno","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Lo","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-9043","authenticated-orcid":false,"given":"Gabriella","family":"Minchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-8465","authenticated-orcid":false,"given":"Anna Chiara","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-1043","authenticated-orcid":false,"given":"Enza","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"7859_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clinicians"},{"key":"7859_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10\u201327.","journal-title":"World J Oncol"},{"key":"7859_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1756-9966-31-68","volume":"31","author":"A Van den Broeck","year":"2012","unstructured":"Van den Broeck A, Vankelecom H, Van Eijsden R, Govaere O, Topal B. Molecular markers associated with outcome and metastasis in human pancreatic cancer. J Exp Clin Cancer Res. 2012;31:68.","journal-title":"J Exp Clin Cancer Res"},{"key":"7859_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-471","volume":"14","author":"GK Gresham","year":"2014","unstructured":"Gresham GK, Wells GA, Gill S, Cameron C, Jonker DJ. Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis. BMC Cancer. 2014;14:471.","journal-title":"BMC Cancer"},{"key":"7859_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-022-02301-9","volume":"41","author":"T Shinkawa","year":"2022","unstructured":"Shinkawa T, Ohuchida K, Mochida Y, Sakihama K, Iwamoto C, Abe T, et al. Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. J Exp Clin Cancer Res. 2022;41:89.","journal-title":"J Exp Clin Cancer Res"},{"key":"7859_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17:487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7859_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"7859_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-022-02516-w","volume":"41","author":"DD Cave","year":"2022","unstructured":"Cave DD, Buonaiuto S, Sainz B, Fantuz M, Mangini M, Carrer A, et al. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer. J Exp Clin Cancer Res. 2022;41:315.","journal-title":"J Exp Clin Cancer Res"},{"key":"7859_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214:579\u201396.","journal-title":"J Exp Med"},{"key":"7859_CR10","doi-asserted-by":"publisher","first-page":"e0188870","DOI":"10.1371\/journal.pone.0188870","volume":"12","author":"TJ Puls","year":"2017","unstructured":"Puls TJ, Tan X, Whittington CF, Voytik-Harbin SL. 3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT. PLoS One. 2017;12:e0188870.","journal-title":"PLoS One"},{"key":"7859_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","volume":"568","author":"I Elia","year":"2019","unstructured":"Elia I, Rossi M, Stegen S, Broekaert D, Doglioni G, Van Gorsel M, et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature. 2019;568:117\u201321.","journal-title":"Nature"},{"key":"7859_CR12","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1158\/0008-5472.CAN-18-2070","volume":"79","author":"C D\u2019Aniello","year":"2019","unstructured":"D\u2019Aniello C, Cermola F, Palamidessi A, Wanderlingh LG, Gagliardi M, Migliaccio A, et al. Collagen prolyl hydroxylation\u2013dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and cancer cells. Cancer Res. 2019;79:3235\u201350.","journal-title":"Cancer Res"},{"key":"7859_CR13","doi-asserted-by":"publisher","unstructured":"Ippolito L, Duatti A, Iozzo M, Comito G, Pardella E, Lorito N et al. Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. EMBO Rep. 2024. https:\/\/doi.org\/10.1038\/s44319-024-00180-z.","DOI":"10.1038\/s44319-024-00180-z"},{"key":"7859_CR14","doi-asserted-by":"crossref","unstructured":"Qiu B, Wei F, Sun X, Wang X, Duan B, Shi C et al. Measurement of hydroxyproline in collagen with three different methods. Mol Med Rep. 2014;10:1157\u201363.","DOI":"10.3892\/mmr.2014.2267"},{"key":"7859_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22490-9","volume":"12","author":"C Tian","year":"2021","unstructured":"Tian C, Huang Y, Clauser KR, Rickelt S, Lau AN, Carr SA, et al. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Nat Commun. 2021;12:2328.","journal-title":"Nat Commun"},{"key":"7859_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16031","volume":"8","author":"O Olivares","year":"2017","unstructured":"Olivares O, Mayers JR, Gouirand V, Torrence ME, Gicquel T, Borge L, et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017;8:16031.","journal-title":"Nat Commun"},{"key":"7859_CR17","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","volume":"39","author":"DD Cave","year":"2020","unstructured":"Cave DD, Di Guida M, Costa V, Sevillano M, Ferrante L, Heeschen C, et al. TGF-\u03b21 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Oncogene. 2020;39:4271\u201385.","journal-title":"Oncogene"},{"key":"7859_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.yexcr.2014.10.021","volume":"330","author":"D-Y Tang","year":"2015","unstructured":"Tang D-Y, Yu Y, Zhao X-J, Schachner M, Zhao W-J. Single chain fragment variable antibodies developed by using as target the 3rd fibronectin type III homologous repeat fragment of human neural cell adhesion molecule L1 promote cell migration and neuritogenesis. Exp Cell Res. 2015;330:336\u201345.","journal-title":"Exp Cell Res"},{"key":"7859_CR19","doi-asserted-by":"publisher","first-page":"s1210","DOI":"10.2741\/1108","volume":"8","author":"M Grumet","year":"2003","unstructured":"Grumet M. The L1CAM extracellular region a multi-domain protein with modular and cooperative binding modes. Front Biosci. 2003;8:s1210\u20131225.","journal-title":"Front Biosci"},{"key":"7859_CR20","doi-asserted-by":"crossref","unstructured":"Ganesh, K. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat Cancer. 2020;1:28\u201345.","DOI":"10.1038\/s43018-019-0006-x"},{"key":"7859_CR21","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.7150\/thno.54027","volume":"11","author":"DD Cave","year":"2021","unstructured":"Cave DD, Hernando-Momblona X, Sevillano M, Minchiotti G, Lonardo E. Nodal-induced L1CAM\/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids. Theranostics. 2021;11:5686\u201399.","journal-title":"Theranostics"},{"key":"7859_CR22","first-page":"1109","volume":"22","author":"C Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der C, Schumacher U, Fogel M, Feuerhake F, M\u00fcller V, Wirtz RM, et al. Milde-Langosch. Expression and prognostic value of L1-CAM in breast cancer. Oncol Rep. 2009;22:1109\u201317.","journal-title":"Oncol Rep"},{"key":"7859_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13046-021-02117-z","volume":"40","author":"M Giordano","year":"2021","unstructured":"Giordano M, Decio A, Battistini C, Baronio M, Bianchi F, Villa A, et al. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1\/SRC\/STAT3 signaling. J Exp Clin Cancer Res. 2021;40:319.","journal-title":"J Exp Clin Cancer Res"},{"key":"7859_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.29658","volume":"138","author":"P Altevogt","year":"2016","unstructured":"Altevogt P, Doberstein K, Fogel M. L1CAM in human cancer. Int J Cancer. 2016;138:1565\u201376.","journal-title":"Int J Cancer"},{"key":"7859_CR25","unstructured":"Kaifi JT, Heidtmann S, Schurr PG, Reichelt U, Mann O, Yekebas EF et al. Absence of L1 in pancreatic masses distinguishes adenocarcinomas from poorly differentiated neuroendocrine carcinomas. Anticancer Res. 2006;26:1167\u201370."},{"key":"7859_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jso.21880","volume":"103","author":"S Tsutsumi","year":"2011","unstructured":"Tsutsumi S, Morohashi S, Kudo Y, Akasaka H, Ogasawara H, Ono M, et al. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma: L1CAM Expression in Pancreatic Cancer. J Surg Oncol. 2011;103:669\u201373.","journal-title":"J Surg Oncol"},{"key":"7859_CR27","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1245\/s10434-010-0955-x","volume":"17","author":"Q-W Ben","year":"2010","unstructured":"Ben Q-W, Wang J-C, Liu J, Zhu Y, Yuan F, Yao W-Y, et al. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2010;17:2213\u201321.","journal-title":"Ann Surg Oncol"},{"key":"7859_CR28","doi-asserted-by":"publisher","unstructured":"Sebens M\u00fcerk\u00f6ster. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep. 2010;24. https:\/\/doi.org\/10.3892\/or.2010.909.","DOI":"10.3892\/or.2010.909"},{"key":"7859_CR29","doi-asserted-by":"publisher","first-page":"111844","DOI":"10.1016\/j.biopha.2021.111844","volume":"141","author":"S Osman","year":"2021","unstructured":"Osman S, Raza A, Al-Zaidan L, Inchakalody VP, Merhi M, Prabhu KS, et al. Anti-cancer effects of Tranilast: an update. Biomed Pharmacother. 2021;141:111844.","journal-title":"Biomed Pharmacother"},{"key":"7859_CR30","doi-asserted-by":"publisher","first-page":"viii10","DOI":"10.1093\/annonc\/mdy268.035","volume":"29","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Nishikawa S, Miyata R, Noguchi M, Ishikawa H, Yutaka Y, et al. Tranilast inhibits TGF-beta-induced EMT and invasion\/metastasis via the suppression of smad4 in lung cancer cell lines. Ann Oncol. 2018;29:viii10.","journal-title":"Ann Oncol"},{"key":"7859_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","volume":"116","author":"H Yamada","year":"1994","unstructured":"Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem. 1994;116:892\u20137.","journal-title":"J Biochem"},{"key":"7859_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2011.10.001","volume":"9","author":"E Lonardo","year":"2011","unstructured":"Lonardo E, Hermann PC, Mueller M-T, Huber S, Balic A, Miranda-Lorenzo I, et al. Nodal\/activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell. 2011;9:433\u201346.","journal-title":"Cell Stem Cell"},{"key":"7859_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00747-6","volume":"19","author":"A Varone","year":"2021","unstructured":"Varone A, Amoruso C, Monti M, Patheja M, Greco A, Auletta L, et al. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function. Cell Commun Signal. 2021;19:64.","journal-title":"Cell Commun Signal"},{"key":"7859_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"7859_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00776-9","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin W, Noel P, Borazanci EH, Lee J, Amini A, Han IW, et al. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Med. 2020;12:80.","journal-title":"Genome Med"},{"key":"7859_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-021-00663-1","volume":"7","author":"Q Xu","year":"2021","unstructured":"Xu Q, Chen S, Hu Y, Huang W. Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma. Cell Death Discov. 2021;7:331.","journal-title":"Cell Death Discov"},{"key":"7859_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun B-F, Chen C-Y, Zhou J-Y, Chen Y-S, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725\u201338.","journal-title":"Cell Res"},{"key":"7859_CR38","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/nar\/gkz116","volume":"47","author":"P Xie","year":"2019","unstructured":"Xie P, Gao M, Wang C, Zhang J, Noel P, Yang C, et al. SuperCT: a supervised-learning framework for enhanced characterization of single-cell transcriptomic profiles. Nucleic Acids Res. 2019;47:e48\u2013e48.","journal-title":"Nucleic Acids Res"},{"key":"7859_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104659","volume":"25","author":"R Chijimatsu","year":"2022","unstructured":"Chijimatsu R, Kobayashi S, Takeda Y, Kitakaze M, Tatekawa S, Arao Y, et al. Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma. iScience. 2022;25:104659.","journal-title":"iScience"},{"key":"7859_CR40","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1021\/acs.jpcb.9b05006","volume":"123","author":"S Xu","year":"2019","unstructured":"Xu S, Gu M, Wu K, Li G. Unraveling the role of hydroxyproline in maintaining the thermal stability of the collagen triple helix structure using simulation. J Phys Chem B. 2019;123:7754\u201363.","journal-title":"J Phys Chem B"},{"key":"7859_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm6010011","volume":"6","author":"T Yokobori","year":"2017","unstructured":"Yokobori T, Nishiyama M. TGF-\u03b2 signaling in gastrointestinal cancers: progress in basic and clinical research. JCM. 2017;6:11.","journal-title":"JCM"},{"key":"7859_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W-L. Drug repurposing for cancer therapy. Sig Transduct Target Ther. 2024;9:92.","journal-title":"Sig Transduct Target Ther"},{"key":"7859_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13046-024-03072-1","volume":"43","author":"E Ibello","year":"2024","unstructured":"Ibello E, Saracino F, Delle Cave D, Buonaiuto S, Amoroso F, Andolfi G, et al. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism. J Exp Clin Cancer Res. 2024;43:165.","journal-title":"J Exp Clin Cancer Res"},{"key":"7859_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MPA.0b013e3181967670","volume":"38","author":"O Zion","year":"2009","unstructured":"Zion O, Genin O, Kawada N, Yoshizato K, Roffe S, Nagler A, et al. Inhibition of transforming growth factor \u03b2 signaling by halofuginone as a modality for pancreas fibrosis prevention. Pancreas. 2009;38:427\u201335.","journal-title":"Pancreas"},{"key":"7859_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122352120","volume":"120","author":"F Alemanno","year":"2023","unstructured":"Alemanno F, Cavo M, Delle Cave D, Fachechi A, Rizzo R, D\u2019Amone E, et al. Quantifying heterogeneity to drug response in cancer\u2013stroma kinetics. Proc Natl Acad Sci USA. 2023;120:e2122352120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7859_CR46","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/ijms25031631","volume":"25","author":"C Adamopoulos","year":"2024","unstructured":"Adamopoulos C, Cave DD, Papavassiliou AG. Inhibition of the RAF\/MEK\/ERK signaling cascade in pancreatic cancer: recent advances and future perspectives. IJMS. 2024;25:1631.","journal-title":"IJMS"},{"key":"7859_CR47","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-22-1630","volume":"29","author":"Y Boucher","year":"2023","unstructured":"Boucher Y, Posada JM, Subudhi S, Kumar AS, Rosario SR, Gu L, et al. Addition of Losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, tregs, and FOXP3+ cancer cells in locally advanced pancreatic cancer. Clin Cancer Res. 2023;29:1605\u201319.","journal-title":"Clin Cancer Res"},{"key":"7859_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847334","volume":"20","author":"M Pein","year":"2019","unstructured":"Pein M, Oskarsson T. Tamoxifen calms down the distressed PDAC stroma. EMBO Rep. 2019;20:e47334.","journal-title":"EMBO Rep"},{"key":"7859_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2021.03.006","volume":"82","author":"LNC Boyd","year":"2022","unstructured":"Boyd LNC, Andini KD, Peters GJ, Kazemier G, Giovannetti E. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment. Semin Cancer Biol. 2022;82:184\u201396.","journal-title":"Semin Cancer Biol"},{"key":"7859_CR50","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1111\/cas.15952","volume":"114","author":"R Kashiwagi","year":"2023","unstructured":"Kashiwagi R, Funayama R, Aoki S, Matsui A, Klein S, Sato Y, et al. Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. Cancer Sci. 2023;114:4286\u201398.","journal-title":"Cancer Sci"},{"key":"7859_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/1078-0432.CCR-20-2298","volume":"27","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Masugi Y, Abe T, Yamazaki K, Ueno A, Fujii-Nishimura Y, et al. Three distinct stroma types in human pancreatic cancer identified by image analysis of fibroblast subpopulations and collagen. Clin Cancer Res. 2021;27:107\u201319.","journal-title":"Clin Cancer Res"},{"key":"7859_CR52","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.2147\/IJN.S480168","volume":"19","author":"D Delle Cave","year":"2024","unstructured":"Delle Cave D, Mangini M, Tramontano C, De Stefano L, Corona M, Rea I, et al. Hybrid biosilica nanoparticles for in-vivo targeted inhibition of colorectal cancer growth and label-free imaging. IJN. 2024;19:12079\u201398.","journal-title":"IJN"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07859-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:12:12Z","timestamp":1757344332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7859"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07859-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Italian Ministry of Health (IACUC protocol n\u00b01010\/2023-PR) prior to the commencement of the study. All the procedures were performed in the animal facility at IGB-CNR under pathogen-free conditions in accordance with Regulations for the Council Directive 2010\/63\/EU on the protection of animals used for scientific and experimental purposes. The IGB-CNR animal facility is authorized by the Ministry of Health according to the Italian law on animal experimentation (D.L. 26\/2014). All experiments were performed in accordance with the approved protocol and the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"592"}}